Weight-Loss Boom Pushes Eli Lilly’s 2026 Revenue Forecast to as Much as $92 Billion
Mounjaro and Zepbound brought in about $16.1 billion in the third quarter, so Lilly raised its full-year revenue outlook to $91–92 billion while trimming its profit view on deal charges.